Barfresh Food Group Inc. — Q3 2023 Form 10-Q Summary
Business Context and Reporting Period
Barfresh manufactures and distributes ready-to-drink and ready-to-blend frozen beverages, including smoothies, shakes and frappes. The filing covers the unaudited three and nine months ended September 30, 2023, compared with restated 2022 periods. The company is a smaller reporting company and emerging growth company.
Key Financial Metrics
| Metric | Q3 2023 | Q3 2022 Restated | 9M 2023 | 9M 2022 Restated |
|---|---|---|---|---|
| Revenue | $2.603 million | $2.406 million | $6.205 million | $7.731 million |
| Gross profit | $0.913 million | $(0.723) million | $2.242 million | $0.924 million |
| Gross margin | 35% | (30%) | 36% | 12% |
| Operating expenses | $1.389 million | $1.964 million | $4.365 million | $5.200 million |
| Net loss | $(0.476) million | $(2.687) million | $(2.123) million | $(4.276) million |
| Net loss per share | $(0.04) | $(0.21) | $(0.16) | $(0.33) |
| Operating cash flow | Not separately provided | Not separately provided | $(2.008) million | $(2.619) million |
- Cash was $1.011 million at September 30, 2023, versus $2.808 million at December 31, 2022. Working capital was $0.541 million, compared with $1.801 million at year-end 2022.
- Total liabilities were $2.660 million and stockholders’ equity was $1.293 million at September 30, 2023. The company had no recorded debt at the quarter-end balance-sheet date.
- Accounts receivable increased to $1.159 million from $0.126 million at December 31, 2022, while inventory declined to $0.748 million from $1.048 million.
- Operating cash use improved from the prior-year period but remained significant. Cash used in operations included a $1.033 million increase in accounts receivable.
Material Changes Versus the Prior Comparable Period
- Q3 revenue increased 8% on a reported basis, but management stated that revenue declined 14% based on product shipped after excluding a $0.630 million 2022 claims estimate related to withdrawn product.
- Nine-month revenue declined 20% on a reported basis and 26% based on product shipped after excluding the 2022 claims estimate.
- Gross margin improved substantially. Management attributed the improvement to favorable product mix, pricing actions and modestly lower supply-chain component costs. The comparison also benefited from the absence of a $0.932 million inventory write-off in 2022.
- Q3 selling, marketing and distribution expense decreased 19% to $0.697 million; nine-month expense decreased 11% to $1.990 million.
- Q3 general and administrative expense decreased 43% to $0.578 million; nine-month expense decreased 22% to $2.065 million. Reductions reflected lower personnel, professional-service and research-and-development costs, partly offset by higher stock-based compensation.
- The company recorded $0.496 million of stock-based compensation during the first nine months of 2023, compared with $0.211 million in the prior-year period.
Guidance, Outlook, Risks and Unusual Items
- Management expects additional smoothie-bottle manufacturing capacity may become available in early 2024, subject to contracting and pre-production risks. The company does not provide formal revenue or earnings guidance.
- A dispute with a former contract manufacturer remains material. The company withheld $0.499 million of disputed accounts payable after product-quality issues and market withdrawals, and re-filed its complaint in California state court in August 2023. The outcome and any potential recovery cannot be estimated.
- The manufacturer dispute caused supply constraints, customer losses and adverse effects on revenue, cash flow and operating results. Carton packaging partially mitigated the disruption but has not been accepted by all customers as a substitute for bottles.
- Vendor concentration remains a supply risk: for the nine months ended September 30, 2023, Manufacturer A represented 47% and Manufacturer B 44% of finished-goods purchases.
- From July through October 2023, the company obtained commitments for $1.880 million of a planned $2.000 million convertible-debt offering. On October 23, 2023, it drew $1.390 million; $1.207 million of principal and interest was immediately converted into approximately 820,000 common shares. The remaining pro forma convertible notes payable was $0.183 million.
- The convertible debt bears interest at 10% annually and includes mandatory and holder conversion provisions. Further conversion could dilute existing shareholders.
- Nasdaq had granted the company until October 30, 2023 to regain compliance with its minimum-equity requirement. The October financing and conversion produced pro forma stockholders’ equity of $2.500 million, below the stated $2.500 million threshold only due to rounding presentation; Nasdaq will continue monitoring compliance and may pursue delisting if compliance is not demonstrated in a subsequent filing.
- Management concluded that the company’s disclosure controls and procedures were not effective as of September 30, 2023 because of a material weakness involving the control environment and inadequate segregation of duties, including information-technology controls. The filing also restated prior financial information to correct depreciation errors.
- Management stated that the identified liquidity indicators did not raise substantial doubt about going-concern status at September 30, 2023, but acknowledged uncertainty regarding additional financing and other liquidity actions. Continued operating losses and negative cash flow remain significant risks.
Important Facts for Investors to Verify
- Whether Nasdaq confirms continued compliance with the minimum-stockholders’-equity requirement after the October 2023 financing and conversion.
- The timing, cost and reliability of the planned additional bottle-manufacturing capacity.
- The financial and operational outcome of the manufacturer litigation, including the disputed $0.499 million payable and any potential recovery or liability.
- Whether revenue and customer volumes recover from supply constraints and limited acceptance of carton packaging.
- The company’s ability to fund operations as cash declines and operating cash flow remains negative.
- The terms, outstanding balance, interest cost and potential dilution associated with the convertible notes.
- Progress in remediating the material weakness in internal control over financial reporting.